Variant report
Variant | nsv462983 |
---|---|
Chromosome Location | chr6:66091351-66125723 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:66097248..66097748-chr7:48217360..48217884,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185357925 | chr6:66095823-66095824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190135503 | chr6:66095828-66095829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569635523 | chr6:66095847-66095848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146858566 | chr6:66095872-66095873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6921968 | chr6:66095907-66095908 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs182305365 | chr6:66095911-66095912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114540674 | chr6:66095951-66095952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548349427 | chr6:66095956-66095957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574836350 | chr6:66095967-66095968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543659405 | chr6:66096004-66096005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9354235 | chr6:66096011-66096012 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs71646067 | chr6:66096075-66096076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs145422218 | chr6:66096081-66096082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577629728 | chr6:66096130-66096131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528798838 | chr6:66096148-66096149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75163628 | chr6:66096150-66096151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564903998 | chr6:66096181-66096182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527278849 | chr6:66096182-66096183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534470951 | chr6:66096193-66096194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540978317 | chr6:66096202-66096203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139612643 | chr6:66096206-66096207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185747246 | chr6:66096244-66096245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188122181 | chr6:66096257-66096258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9345616 | chr6:66096273-66096274 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs144347458 | chr6:66096276-66096277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9345617 | chr6:66096277-66096278 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs180878803 | chr6:66096293-66096294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34422988 | chr6:66096299-66096300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534718265 | chr6:66096301-66096302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71002304 | chr6:66096309-66096310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs28631876 | chr6:66096310-66096311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201411328 | chr6:66096311-66096312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374309168 | chr6:66096325-66096326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146578856 | chr6:66096359-66096360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs149126805 | chr6:66096407-66096408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557305292 | chr6:66096431-66096432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373213317 | chr6:66096465-66096466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557625920 | chr6:66096506-66096507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs577493958 | chr6:66096516-66096517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185282700 | chr6:66096611-66096612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553709378 | chr6:66096618-66096619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9342472 | chr6:66096622-66096623 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs369347054 | chr6:66096629-66096630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540689758 | chr6:66096761-66096762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs16896632 | chr6:66096784-66096785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574481751 | chr6:66096822-66096823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190192062 | chr6:66096890-66096891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34569665 | chr6:66096891-66096892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs398001835 | chr6:66096898-66096899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs528606884 | chr6:66096908-66096909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-syndromic sensorineural hearing loss | 19212409 | CNVD |
Cancer | 20164919 | CNVD |
Retinitis pigmentosa | 21519034 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66095800-66097200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr6:66096600-66097000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr6:66099200-66099600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr6:66108200-66109200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr6:66109200-66110000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr6:66110000-66110200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr6:66120200-66120600 | Enhancers | HepG2 | liver |
8 | chr6:66124200-66124400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr6:66124400-66125000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr6:66125000-66127800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr6:66125200-66127800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |